How about Weigao Group

Weigao Group was founded in 1988, with disposable medical devices and pharmaceuticals as the leading, the development of aerospace military, real estate, securities investment and other five industries, covers an area of more than 2 million square meters, with a total asset of more than 10 billion yuan, more than 12,000 employees, under the jurisdiction of the 20 subsidiaries, the controlling subsidiary of the Shandong Weigao Group of Medical Polymer Products Co. Ltd. was listed on the Hong Kong Growth Enterprise Market in February 2004, and in July 2010, it was listed on the Main Board. The Group owns more than 300 kinds of medical devices and medicines with more than 30,000 specifications, mainly including infusion consumables, surgical sutures, medical catheters, cardiac stents and intracardiac consumables, indwelling needles and all kinds of shaped needles, blood purification equipments and consumables, orthopaedic materials, medical equipments, therapeutic injections and other medicines, bio-diagnostic reagents, synthetic plasma, bio-implants, PVC and non-PVC raw materials, etc., and has become China's largest single-use medical device company, which has been recognized as one of the most important medical products in China. It has become the largest single-use medical device manufacturer in China, and is a national 863 industrialization base and a key high-tech enterprise under the National Torch Plan. It has been honored as a leading enterprise in the industry, a national contract-abiding and credit-abiding enterprise, one of the top 500 Chinese large enterprise groups in terms of competitiveness, one of the top 500 Chinese enterprises in terms of informatization, one of the top 500 Chinese enterprises in terms of patent in Shandong Province, and the first one of the most bidding-strength brand suppliers of medical devices in China, Shandong Province, Shandong Province, the outstanding contribution to cooperation and innovation of industry-university-research award, Shandong Province, Shandong Province, the best corporate citizens, Shandong Province, the first batch of integrity demonstration enterprises and other honorary titles.

The company has a sound technological innovation system, with a national enterprise technology center, national engineering laboratories, academician workstations, post-doctoral research stations, provincial enterprise technology centers. Adhering to the road of cooperation between industry, academia and research, the company has established 9 R&D centers off-site in cooperation with Chinese Academy of Sciences (CAS) and Changchun, Dalian and Shenyang institutes of CAS, 301 Hospital, the Third Military Medical University, Harvard University of Technology, and Shenyang Pharmaceutical University, etc., and has been vigorously developing high-tech and high-value-added products with independent intellectual property rights. 2010 is the first year in which the company has implemented the CAS - Wigao Group High-Tech Research and Development Program in cooperation with the Chinese Academy of Sciences (CAS). Weigao Group High Technology Research and Development Program. At present, Weigao owns more than 200 patented products, of which more than 80 products have filled the gaps in China and reached the advanced level at home and abroad, breaking the monopoly of multinational corporations, and more than 20 projects (cardiac stents, polysulfone membrane dialyzers, spinal endoprostheses, central venous catheters, genistein A immunosorbent columns, self-destructing safety syringes, plasma separators, and light-absorbing syringes, etc.) have been listed in the National Key Torch Program, The products are included in the National Key Torch Program, National 863 Program, National High-tech Industrial Demonstration Project, National Key New Products and other national programs.

Weigao Group persistently implements the famous brand strategy and cultivates famous brands. The trademark of "JERUI" is recognized as "Famous Trademark of China", and "JERUI Brand Single-use Sterile Infusion Medical Devices" is awarded the title of "Famous Brand Product of China". The brand of "JERY" was recognized as "China Famous Trademark" and "JERY Disposable Sterile Infusion Medical Devices" was awarded as "China Famous Brand Product". The company has established more than 100 sales offices in more than 30 provinces, municipalities and autonomous regions, and has established long-term and stable relationships with more than 7,000 hospitals, 400 blood stations and 1,800 commercial companies. Our products not only sell well in more than 30 provinces, cities and autonomous regions in China, but also directly exported to the United States, the European Union, Russia, South Africa, Brazil and other more than 50 countries and regions.

Weigao Group actively participates in social welfare and charitable undertakings, and actively returns to the society. In recent years, it has carried out activities such as Weigao Bright Action, Weigao Love Project, Ten Filial Piety Stars Selection, subscription to charitable funds, natural disaster donations, etc., with a cumulative donation of more than 200 million yuan.

Weigao takes the mission of "Bringing together the white-clothed messengers to create a healthy future" as its mission, establishes the core values of conscience, sincerity and loyalty, builds a century-long evergreen foundation, and strides towards the visionary goal of "a medical device and pharmaceutical enterprise with world competitiveness, leading position in Asia, and the most respectable". We will make greater contributions to the healthy development of China's medical and healthcare industry by building a century-old foundation and marching forward to the vision and goal of "world competitiveness, Asia's leading and most respected medical device and pharmaceutical enterprise".